Ampyra available for multiple sclerosis patients

AMPRYA (dalfampridine) 10mg extended release tablets by Elan and Acorda Therapeutics
AMPRYA (dalfampridine) 10mg extended release tablets by Elan and Acorda Therapeutics
Acorda Therapeutics has made available Ampyra (dalfampridine extended-release tablets) as a treatment to improve walking in patients with multiple sclerosis (MS). Ampyra is indicated for use in all types of MS, and can be used either alone or with existing therapies, including disease-modifying agents.

Ampyra is available in a 10mg dosage strength.

For more information call (888) 881-1918 or visit www.ampyra.com.